Our mission is to become a worldwide reference for education in the field for all professionals involved in the process to disseminate knowledge & skills of Acute Cardiovascular Care.
Our mission is to promote excellence in clinical diagnosis, research, technical development, and education in cardiovascular imaging in Europe.
Our mission is to promote excellence in research, practice, education and policy in cardiovascular health, primary and secondary prevention.
Our mission is to reduce the burden of cardiovascular disease in Europe through percutaneous cardiovascular interventions.
Our mission is to improve the quality of life of the population by reducing the impact of cardiac rhythm disturbances and reduce sudden cardiac death.
Our mission is to improve quality of life and longevity, through better prevention, diagnosis and treatment of heart failure, including the establishment of networks for its management, education and research.
The ESC Working Groups' goal is to stimulate and disseminate scientific knowledge in different fields of cardiology.
The ESC Councils' goal is to share knowledge among medical professionals practising in specific cardiology domains.
OUR MISSION: TO REDUCE THE BURDEN OF CARDIOVASCULAR DISEASE
After five years in the editor's chair, Professor Karl Swedberg steps down in January as editor-in-chief of the European Journal of Heart Failure, a journal of the European Society of Cardiology.
His successor is Professor Dirk van Veldhuisen from the Department of Cardiology at the University Medical Center Groningen, in the Netherlands. Professor van Veldhuisen brings with him two Groningen colleagues as new deputy editors, Professor Wiek van Gilst, a clinical pharmacologist who is Head of the Department of Experimental Cardiology, and Dr Adriaan Voors, a clinical cardiologist involved in a large number of heart failure trials, including the European heart failure project, BIOSTAT-CHF.
Under Professor Swedberg's editorship - and in the wake of ever increasing submissions - the EJHF has progressed from bimonthly to monthly publication, and its impact factor has risen to 3.4 (based on citations for 2006-2007). Around 650 manuscripts are now submitted each year, with lead time from acceptance to online publication as little as three weeks. "We are proud of this achievement," reports Professor Swedberg.
Professor van Veldhuisen aims to continue this remarkable growth and improvement, and to make the EJHF "the most prominent heart failure journal", and "the world forum for good - clinical and basic - heart failure research". Competition, of course, lurks across the Atlantic, but strengths in Europe lie with the ESC's family of journals, notably the European Heart Journal, and the manuscript transfer system which operates among them. "Many good papers that for some reason just do not make it into the European Heart Journal still represent very good studies, and can get reviewed and published very quickly via this new system," says Professor van Veldhuisen.
Professor Swedberg, who describes his five years editing the journal as "interesting and valuable", will remain a consulting editor to the EJHF, and the editorial office will remain in Hull, UK. Expectations are, therefore, that the transition from one editor to the next will be seamless and that the journal will continue its rapidly increasing growth.
* The EJHF is published on behalf of the Heart Failure Association of the European Society of Cardiology. The first issue appeared in January 1999 under the editorship of Professor John Cleland.
The European Society of Cardiology (ESC) represents more than 62,000 cardiology professionals across Europe and the Mediterranean. Its mission is to reduce the burden of cardiovascular disease in Europe.
© 2017 European Society of Cardiology. All rights reserved